← Evidence map

ArticleFrontiers in pharmacology2019

Clinical Prescription-Protein-Small Molecule-Disease Strategy (CPSD), A New Strategy for Chinese Medicine Development: A Case Study in Cardiovascular Diseases.

Yong-Zhi Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019
2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32038243